Treat epilepsy with cannabis?

In Australia, a pioneering study was conducted on medicinal cannabis, that is, on the use of the prohibited plant for healing purposes. Today, as you know, it is used for many pathologies. This time it was adopted to treat children with epilepsy.
But not just any epilepsy. Those cases of epilepsy resistant to traditional treatments.
And contrary to what parents thought, the cannabis used had something different.

The study showed that the main psychoactive ingredient of cannabis, tetrahydrocannabidiol (THC), and the closely related compound THCA, were present in most of the extracts, but the quantity was generally not sufficient to produce intoxicating effects.

The Food and Drug Administration has approved Epidiolex, tested in three randomized, placebo-controlled clinical trials involving 516 patients with Lennox-Gastaut syndrome or Dravet syndrome.
„CBD – writes the FDA in its note – is the chemical component of the plant commonly known as marijuana that does not cause intoxication or the euphoria that entails tetrahydrocannabidiol (Thc). Thc (and not CBD) – states the note – is the main psychoactive component of marijuana „.
„This approval – said Commissioner Fda Scott Gottlieb – serves as a reminder that the advancement of development programs that correctly evaluate the active ingredients contained in marijuana can lead to important medical therapies. And the FDA is engaged in this type of careful scientific research and drug development. Controlled clinical trials that test the safety and efficacy of a drug, together with careful review through the FDA approval process, are the most appropriate way to bring marijuana-based treatments to patients. Due to the adequate and well-controlled clinical trials that have supported this approval, prescribers may have confidence in the uniform strength of the drug and the consistent administration that supports the appropriate administration necessary for the treatment of patients with these complex and severe epileptic syndromes. We will continue to support rigorous scientific research into the potential medical uses of marijuana products and we will work with product developers interested in offering patients safe, effective and high quality products. But, at the same time, we are ready to take action against illegal marketing of Cbd-containing products with unproven medical claims. The marketing of unapproved products, with uncertain dosages and formulations, can prevent patients from accessing appropriate and recognized therapies for the treatment of diseases.



3 Kommentare

  1. In the mid 70s I had a good friend who became epileptic at 13 years of age. He had the grand mal variety that made him take easily a dozen pills several times a day that would have knocked out anyone else. He was treated at the Heidelberg University Klinik, where the doctor was worried about the amount of drugs this young man had to take to be seizure free. My friend met a new friend during that time who had turned him on to hashish (marihuana was not available in Germany at that time). I became aware of this and asked him about it. He said that not only did he like the serenity, but he had stopped his medication because his seizures had stopped. I haven’t seen him since, but he was well as long as I kept up with him.


Kommentar verfassen

Trage deine Daten unten ein oder klicke ein Icon um dich einzuloggen:

Du kommentierst mit deinem Abmelden /  Ändern )


Du kommentierst mit deinem Facebook-Konto. Abmelden /  Ändern )

Verbinde mit %s

Diese Seite verwendet Akismet, um Spam zu reduzieren. Erfahre, wie deine Kommentardaten verarbeitet werden..